New Study Shows How Mutations in SARS-CoV-2 Allow the Virus to Evade Immune System Defenses

Research reveals how mutated SARS-CoV-2 evades immune system defenses

In lab-dish experiments, the mutant virus escaped antibodies from the plasma of

COVID-19 survivors as well as pharmaceutical-grade antibodies

Mutations arose in an immunocompromised patient with chronic SARS-CoV-2 infection

Patient-derived virus harbored structural changes now seen cropping up independently in samples across the globe

Findings underscore the need for better genomic surveillance to keep track of emerging variants

Results highlight importance of therapies aimed at multiple targets on SARS-CoV-2 to minimize risk of resistance

Read more

Rutgers Expert Available to Discuss Coronavirus Risks a Year After Lockdowns Began

New Brunswick, N.J. (March 11, 2021) – Rutgers University–New Brunswick Professor Donald W. Schaffner is available for interviews on the likelihood of becoming infected by

Read more

NCCN provides new COVID-19 treatment advice; updates vaccine guidance for cancer patients

Leading cancer and infectious disease experts analyze latest data and FDA approvals to create evidence-based expert consensus recommendations for both treatment and prevention of COVID-19 for people with cancer

Read more

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.

Read more

More than 1,000 SARS-CoV-2 Coronavirus Protein 3D Structures Available

New Brunswick, N.J. (March 3, 2021) – The 3D structures of more than 1,000 SARS-CoV-2 coronavirus proteins are freely available

Read more

Antibodies recognize and attack different SARS-CoV-2 spike shapes

The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes; new research reveals ways that antibodies can recognize these different shapes and block the virus and informs the design of vaccines and antiviral therapies

Read more

How SARS-CoV-2’s sugar-coated shield helps activate the virus

SARS-CoV-2, the virus that causes COVID-19, is coated with sugars called glycans, which help it evade the immune system; new research shows precisely how those sugars help the virus become activated and infectious and could help with vaccine and drug disc

Read more